Mutual Fund Ownership
Ownership as on: Fri, 14 Jun, 2024

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.38
% of AUM5.58%

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)192.75
% of AUM2.69%

Canara Robeco Focused Equity Fund Regular Growth

NA
Equity
Amount Invested (Cr.)36.14
% of AUM1.58%

LIC MF Aggressive Hybrid Fund Growth

2/5
Hybrid
Amount Invested (Cr.)7.97
% of AUM1.54%

LIC MF Long Term Value Fund Growth

2/5
Equity
Amount Invested (Cr.)1.63
% of AUM1.46%

FAQs about Mankind Pharma share price

Mankind Pharma is trading at 2228.00 as on Fri Jun 14 2024 09:59:59. This is -0.56% lower as compared to its previous closing price of 2240.50.

The market capitalization of Mankind Pharma is 89261.51 Cr as on Fri Jun 14 2024 09:59:59.

The average broker rating on Mankind Pharma is Buy. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 5 analysts have given a buy rating
  • 4 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Mankind Pharma is 2488.65 whereas the 52 wk low is 1467.05

Mankind Pharma can be analyzed on the following key metrics -

  • TTM P/E: 48.18
  • Sector P/E: 34.86
  • Dividend Yield: 0.00%
  • D/E ratio: 0.02

Mankind Pharma reported a net profit of 1912.90 Cr in 2024.

Recommended For You
Trending Stocks
2,927.00+62.95(2.20%)
3,533.75+62.00(1.79%)
1,597.45+16.55(1.05%)
1,370.95-19.15 (-1.38%)
HomeMarketsPremiumInstant LoanGet App